Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1276860

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1276860

MEA Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 284 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Middle East and Africa Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Middle East and Africa Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Middle East and Africa Fluorescent in Situ Hybridization (FISH) market are:

Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine

Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases

Market Players

Some of the major market players operating in the Middle East and Africa Fluorescent in Situ Hybridization (FISH) market are:

Thermo Fisher Scientific Inc.

Bio-Techne

Abbott

Agilent Technologies, Inc.

Merck KGaA

Show more

TABLE OF CONTENTS

1 INTRODUCTION 67

  • 1.1 OBJECTIVES OF THE STUDY 67
  • 1.2 MARKET DEFINITION 67
  • 1.3 OVERVIEW 67
  • 1.4 CURRENCY AND PRICING 69
  • 1.5 LIMITATIONS 69
  • 1.6 MARKETS COVERED 70

2 MARKET SEGMENTATION 73

  • 2.1 MARKETS COVERED 73
  • 2.2 GEOGRAPHICAL SCOPE 74
  • 2.3 YEARS CONSIDERED FOR THE STUDY 75
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 76
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 79
  • 2.6 MULTIVARIATE MODELLING 80
  • 2.7 MARKET APPLICATION COVERAGE GRID 81
  • 2.8 PRODUCT LIFELINE CURVE 82
  • 2.9 DBMR MARKET POSITION GRID 83
  • 2.10 VENDOR SHARE ANALYSIS 85
  • 2.11 SECONDARY SOURCES 86
  • 2.12 ASSUMPTIONS 86

3 EXECUTIVE SUMMARY 87

4 PREMIUM INSIGHTS 90

  • 4.1 PORTER'S FIVE FORCES 91
  • 4.2 PESTEL ANALYSIS 92
  • 4.3 INDUSTRY INSIGHTS 93
  • 4.4 CONCLUSION 94

5 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: REGULATORY FRAMEWORK 95

6 MARKET OVERVIEW 97

  • 6.1 DRIVERS 99
    • 6.1.1 GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER 99
    • 6.1.2 INNOVATION AND ADVANCEMENTS IN FISH PRODUCTS 99
    • 6.1.3 HIGH FUNDING FOR RESEARCH ACTIVITIES 100
    • 6.1.4 RISING DEMAND AND USAGE OF FISH TECHNIQUES 100
  • 6.2 RESTRAINTS 101
    • 6.2.1 HIGH COST OF FISH TESTING 101
    • 6.2.2 LIMITED AVAILABILITY OF SKILLED PROFESSIONALS 101
  • 6.3 OPPORTUNITIES 102
    • 6.3.1 RISING PUBLIC AWARENESS ABOUT THE EARLY DETECTION OF GENETIC ABNORMALITIES 102
    • 6.3.2 RISE IN DEVELOPMENT OF SPECIFIC BIOMARKERS AND VARIOUS PROBES 102
  • 6.4 CHALLENGES 103
    • 6.4.1 STRINGENT GOVERNMENT REGULATIONS FOR THE APPROVAL OF FISH PROBES 103
    • 6.4.2 ETHICAL CONCERNS ASSOCIATED WITH FISH TECHNOLOGY 103

7 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE 104

  • 7.1 OVERVIEW 105
  • 7.2 CONSUMABLES 108
    • 7.2.1 FISH PROBE 108
      • 7.2.1.1 FISH PROBE, BY PROBE TYPE 109
        • 7.2.1.1.1 CHROMOSOME FISH PROBE 109
        • 7.2.1.1.2 SPLIT FISH PROBES 109
        • 7.2.1.1.3 TRANSLOCATION FISH PROBES 109
        • 7.2.1.1.4 SUBTELOMERE FISH PROBES 109
        • 7.2.1.1.5 PRENATAL FISH PROBES 109
        • 7.2.1.1.6 OTHERS PROBES 110
      • 7.2.1.2 FISH PROBE, BY TECHNOLOGY 110
        • 7.2.1.2.1 FLOW FLUORESCENT IN SITU HYBRIDIZATION 110
        • 7.2.1.2.2 C-ISH 110
        • 7.2.1.2.3 D-ISH 110
        • 7.2.1.2.4 Q- FLUORESCENT IN SITU HYBRIDIZATION 110
        • 7.2.1.2.5 OTHERS 110
      • 7.2.1.3 FISH PROBE, BY TYPE 111
        • 7.2.1.3.1 RNA 111
        • 7.2.1.3.1.1 MRNA 111
        • 7.2.1.3.1.2 MIRNA 111
        • 7.2.1.3.1.3 OTHERS 112
        • 7.2.1.3.2 DNA 112
    • 7.2.2 ACCESSORY KITS & REAGENTS 112
      • 7.2.2.1 KITS 112
      • 7.2.2.2 BUFFER 112
      • 7.2.2.3 DYES 112
      • 7.2.2.4 OTHERS 113
  • 7.3 INSTRUMENT 113
    • 7.3.1 STANDALONE 114
    • 7.3.2 PORTABLE 114
    • 7.3.3 HANDHELD 114
  • 7.4 SOFTWARE 114

8 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY 115

  • 8.1 OVERVIEW 116
  • 8.2 RNA FLUORESCENT IN SITU HYBRIDIZATION 119
  • 8.3 DNA FLUORESCENT IN SITU HYBRIDIZATION 120
  • 8.4 PNA FLUORESCENT IN SITU HYBRIDIZATION 121
  • 8.5 OTHERS 122

9 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION 123

  • 9.1 OVERVIEW 124
  • 9.2 CANCER RESEARCH 127
    • 9.2.1 CANCER RESEARCH, BY CANCER TYPE 128
      • 9.2.1.1 NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) 128
        • 9.2.1.1.1 BREAST CANCER 128
        • 9.2.1.1.2 LUNG CANCER 128
        • 9.2.1.1.3 MELANOMA 129
        • 9.2.1.1.4 PROSTRATE CANCER 129
        • 9.2.1.1.5 OVARIAN CANCER 129
        • 9.2.1.1.6 OTHERS 129
      • 9.2.1.2 HEMATOPOETIC MALIGNANCIES 129
        • 9.2.1.2.1 LEUKEMIA 129
        • 9.2.1.2.2 MULTIPLE MYELOMA 130
        • 9.2.1.2.3 MYELODYSPLASTIC SYNDROMES (MDS) 130
    • 9.2.2 CANCER RESEARCH, BY PRODUCT 130
      • 9.2.2.1 CONSUMABLES 130
      • 9.2.2.2 INSTRUMENTS 130
      • 9.2.2.3 SOFTWARE 130
  • 9.3 GENETIC RESEARCH 131
    • 9.3.1 CYTOGENETICS 132
    • 9.3.2 CHROMOSOMAL ABNORMALITIES 132
    • 9.3.3 OTHERS 132
  • 9.4 INFECTIOUS DISEASE 132
    • 9.4.1 CONSUMABLES 133
    • 9.4.2 INSTRUMENTS 133
    • 9.4.3 SOFTWARE 133
  • 9.5 PERSONALIZED MEDICINE 133
  • 9.6 OTHERS 134

10 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE 135

  • 10.1 OVERVIEW 136
  • 10.2 RESEARCH 139
    • 10.2.1 INSTRUMENTS 139
    • 10.2.2 CONSUMABLES 140
    • 10.2.3 SOFTWARE 140
  • 10.3 CLINICAL 140
    • 10.3.1 CONSUMABLES 141
    • 10.3.2 INSTRUMENT 141
    • 10.3.3 SOFTWARE 141
  • 10.4 COMPANION DIAGNOSTIC 141
    • 10.4.1 CONSUMABLES 142
    • 10.4.2 INSTRUMENT 142
    • 10.4.3 SOFTWARE 142

11 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER 143

  • 11.1 OVERVIEW 144
  • 11.2 DIAGNOSTIC LABORATORIES 147
  • 11.3 HOSPITALS & CLINICS 147
  • 11.4 PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES 148
  • 11.5 ACADEMIC & RESEARCH INSTITUTES 149
  • 11.6 CONTRACT RESEARCH ORGANIZATIONS 149
  • 11.7 OTHERS 150

12 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL 151

  • 12.1 OVERVIEW 152
  • 12.2 RETAIL SALES 155
  • 12.3 ONLINE SALES 155
  • 12.4 DIRECT TENDER 156
  • 12.5 OTHERS 157

13 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION 158

  • 13.1 MIDDLE EAST AND AFRICA 159
    • 13.1.1 SOUTH AFRICA 173
    • 13.1.2 SAUDI ARABIA 183
    • 13.1.3 EGYPT 191
    • 13.1.4 UAE 200
    • 13.1.5 KUWAIT 208
    • 13.1.6 QATAR 217
    • 13.1.7 OMAN 225
    • 13.1.8 BAHRAIN 234
    • 13.1.9 REST OF MIDDLE EAST AND AFRICA 242

14 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, COMPANY LANDSCAPE 243

  • 14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 243

15 SWOT ANALYSIS 244

16 COMPANY PROFILE 245

  • 16.1 MERCK KGAA 245
    • 16.1.1 COMPANY SNAPSHOT 245
    • 16.1.2 REVENUE ANALYSIS 245
    • 16.1.3 COMPANY SHARE ANALYSIS 246
    • 16.1.4 PRODUCT PORTFOLIO 246
    • 16.1.5 RECENT DEVELOPMENT 246
  • 16.2 ABBOTT 247
    • 16.2.1 COMPANY SNAPSHOT 247
    • 16.2.2 REVENUE ANALYSIS 247
    • 16.2.3 COMPANY SHARE ANALYSIS 248
    • 16.2.4 PRODUCT PORTFOLIO 248
    • 16.2.5 RECENT DEVELOPMENT 249
  • 16.3 AGILENT TECHNOLOGIES, INC. 250
    • 16.3.1 COMPANY SNAPSHOT 250
    • 16.3.2 REVENUE ANALYSIS 250
    • 16.3.3 COMPANY SHARE ANALYSIS 251
    • 16.3.4 PRODUCT PORTFOLIO 251
    • 16.3.5 RECENT DEVELOPMENT 251
  • 16.4 F. HOFFMANN-LA ROCHE LTD. 252
    • 16.4.1 COMPANY SNAPSHOT 252
    • 16.4.2 REVENUE ANALYSIS 252
    • 16.4.3 COMPANY SHARE ANALYSIS 253
    • 16.4.4 PRODUCT PORTFOLIO 253
    • 16.4.5 RECENT DEVELOPMENT 253
  • 16.5 THERMO FISCHER SCIENTIFIC INC. 254
    • 16.5.1 COMPANY SNAPSHOT 254
    • 16.5.2 REVENUE ANALYSIS 254
    • 16.5.3 COMPANY SHARE ANALYSIS 255
    • 16.5.4 PRODUCT PORTFOLIO 255
    • 16.5.5 RECENT DEVELOPMENT 256
  • 16.6 ABCAM PLC. 257
    • 16.6.1 COMPANY SNAPSHOT 257
    • 16.6.2 REVENUE ANALYSIS 257
    • 16.6.3 COMPANY SHARE ANALYSIS 258
    • 16.6.4 PRODUCT PORTFOLIO 258
    • 16.6.5 RECENT DEVELOPMENTS 258
  • 16.7 ABNOVA CORPORATION 260
    • 16.7.1 COMPANY SNAPSHOT 260
    • 16.7.2 PRODUCT PORTFOLIO 260
    • 16.7.3 RECENT DEVELOPMENT 260
  • 16.8 BIO SB 261
    • 16.8.1 COMPANY SNAPSHOT 261
    • 16.8.2 PRODUCT PORTFOLIO 261
    • 16.8.3 RECENT DEVELOPMENT 261
  • 16.9 BIOCARE MEDICAL, LLC 262
    • 16.9.1 COMPANY SNAPSHOT 262
    • 16.9.2 PRODUCT PORTFOLIO 262
    • 16.9.3 RECENT DEVELOPMENT 263
  • 16.10 BIOCAT GMBH 264
    • 16.10.1 COMPANY SNAPSHOT 264
    • 16.10.2 PRODUCT PORTFOLIO 264
    • 16.10.3 RECENT DEVELOPMENT 265
  • 16.11 BIODOT 266
    • 16.11.1 COMPANY SNAPSHOT 266
    • 16.11.2 PRODUCT PORTFOLIO 266
    • 16.11.3 RECENT DEVELOPMENT 266
  • 16.12 BIOGENEX 267
    • 16.12.1 COMPANY SNAPSHOT 267
    • 16.12.2 PRODUCT PORTFOLIO 267
    • 16.12.3 RECENT DEVELOPMENT 267
  • 16.13 BIO-TECHNE 268
    • 16.13.1 COMPANY SNAPSHOT 268
    • 16.13.2 REVENUE ANALYSIS 268
    • 16.13.3 COMPANY SHARE ANALYSIS 269
    • 16.13.4 PRODUCT PORTFOLIO 269
    • 16.13.5 RECENT DEVELOPMENT 269
  • 16.14 BIOZOL DIAGNOSTICS VERTRIEB GMBH 270
    • 16.14.1 COMPANY SNAPSHOT 270
    • 16.14.2 PRODUCT PORTFOLIO 270
    • 16.14.3 RECENT DEVELOPMENT 271
  • 16.15 EXCILONE 272
    • 16.15.1 COMPANY SNAPSHOT 272
    • 16.15.2 PRODUCT PORTFOLIO 272
    • 16.15.3 RECENT DEVELOPMENT 272
  • 16.16 GENEMED BIOTECHNOLOGIES, INC. 273
    • 16.16.1 COMPANY SNAPSHOT 273
    • 16.16.2 PRODUCT PORTFOLIO 273
    • 16.16.3 RECENT DEVELOPMENT 273
  • 16.17 KANEKA EUROGENTEC S.A. 274
    • 16.17.1 COMPANY SNAPSHOT 274
    • 16.17.2 PRODUCT PORTFOLIO 274
    • 16.17.3 RECENT DEVELOPMENT 274
  • 16.18 LEICA BIOSYSTEMS NUSSLOCH GMBH 275
    • 16.18.1 COMPANY SNAPSHOT 275
    • 16.18.2 PRODUCT PORTFOLIO 275
    • 16.18.3 RECENT DEVELOPMENT 275
  • 16.19 METASYSTEMS 276
    • 16.19.1 COMPANY SNAPSHOT 276
    • 16.19.2 PRODUCT PORTFOLIO 276
    • 16.19.3 RECENT DEVELOPMENT 276
  • 16.20 SYSMEX ASIA PACIFIC PTE LTD (A SUBSIDIARY OF SYSMEX CORPORATION) 277
    • 16.20.1 COMPANY SNAPSHOT 277
    • 16.20.2 REVENUE ANALYSIS 277
    • 16.20.3 PRODUCT PORTFOLIO 278
    • 16.20.4 RECENT DEVELOPMENT 278
Show more
  • 16.21 ZYTOMED SYSTEMS GMBH 279
    • 16.21.1 COMPANY SNAPSHOT 279
    • 16.21.2 PRODUCT PORTFOLIO 279
    • 16.21.3 RECENT DEVELOPMENT 279

17 QUESTIONNAIRE 280

18 RELATED REPORTS 284

LIST OF TABLES

  • TABLE 1 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 2 MIDDLE EAST & AFRICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 68
  • TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 4 MIDDLE EAST & AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 5 MIDDLE EAST & AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 70
  • TABLE 6 MIDDLE EAST & AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 7 MIDDLE EAST & AFRICA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 8 MIDDLE EAST & AFRICA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
  • TABLE 9 MIDDLE EAST & AFRICA INSTRUMENT IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 73
  • TABLE 10 MIDDLE EAST & AFRICA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 73
  • TABLE 11 MIDDLE EAST & AFRICA SOFTWARE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 12 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 78
  • TABLE 13 MIDDLE EAST & AFRICA RNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 79
  • TABLE 14 MIDDLE EAST & AFRICA DNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 80
  • TABLE 15 MIDDLE EAST & AFRICA PNA FLUORESCENT IN SITU HYBRIDIZATION IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 81
  • TABLE 16 MIDDLE EAST & AFRICA OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 82
  • TABLE 17 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 86
  • TABLE 18 MIDDLE EAST & AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 87
  • TABLE 19 MIDDLE EAST & AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 88
  • TABLE 20 MIDDLE EAST & AFRICA NON-HEMATOPOETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 88
  • TABLE 21 MIDDLE EAST & AFRICA HEMATOPOETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 89
  • TABLE 22 MIDDLE EAST & AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 90
  • TABLE 23 MIDDLE EAST & AFRICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 91
  • TABLE 24 MIDDLE EAST & AFRICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 91
  • TABLE 25 MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 92
  • TABLE 26 MIDDLE EAST & AFRICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 93
  • TABLE 27 MIDDLE EAST & AFRICA PERSONALIZED MEDICINE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 94
  • TABLE 28 MIDDLE EAST & AFRICA OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 94
  • TABLE 29 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 98
  • TABLE 30 MIDDLE EAST & AFRICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 99
  • TABLE 31 MIDDLE EAST & AFRICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 99
  • TABLE 32 MIDDLE EAST & AFRICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 100
  • TABLE 33 MIDDLE EAST & AFRICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 101
  • TABLE 34 MIDDLE EAST & AFRICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 102
  • TABLE 35 MIDDLE EAST & AFRICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 102
  • TABLE 36 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 106
  • TABLE 37 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 38 MIDDLE EAST & AFRICA HOSPITALS & CLINICS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 39 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 40 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 109
  • TABLE 41 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATIONS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 42 MIDDLE EAST & AFRICA OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 43 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 114
  • TABLE 44 MIDDLE EAST & AFRICA RETAIL SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 45 MIDDLE EAST & AFRICA ONLINE SALES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 46 MIDDLE EAST & AFRICA DIRECT TENDER IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 47 MIDDLE EAST & AFRICA OTHERS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 48 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 124
  • TABLE 49 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 50 MIDDLE EAST AND AFRICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 51 MIDDLE EAST AND AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 52 MIDDLE EAST AND AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 126
  • TABLE 53 MIDDLE EAST AND AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 54 MIDDLE EAST AND AFRICA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 55 MIDDLE EAST AND AFRICA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 56 MIDDLE EAST AND AFRICA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 57 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 127
  • TABLE 58 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
  • TABLE 59 MIDDLE EAST AND AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 60 MIDDLE EAST AND AFRICA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
  • TABLE 61 MIDDLE EAST AND AFRICA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
  • TABLE 62 MIDDLE EAST AND AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 130
  • TABLE 63 MIDDLE EAST AND AFRICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 64 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
  • TABLE 65 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 131
  • TABLE 66 MIDDLE EAST AND AFRICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 131
  • TABLE 67 MIDDLE EAST AND AFRICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 131
  • TABLE 68 MIDDLE EAST AND AFRICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 132
  • TABLE 69 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 132
  • TABLE 70 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 132
  • TABLE 71 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 72 SOUTH AFRICA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 73 SOUTH AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 74 SOUTH AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 134
  • TABLE 75 SOUTH AFRICA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 76 SOUTH AFRICA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 77 SOUTH AFRICA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 78 SOUTH AFRICA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 79 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 136
  • TABLE 80 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
  • TABLE 81 SOUTH AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 82 SOUTH AFRICA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
  • TABLE 83 SOUTH AFRICA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
  • TABLE 84 SOUTH AFRICA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 139
  • TABLE 85 SOUTH AFRICA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
  • TABLE 86 SOUTH AFRICA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
  • TABLE 87 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 140
  • TABLE 88 SOUTH AFRICA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 140
  • TABLE 89 SOUTH AFRICA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 140
  • TABLE 90 SOUTH AFRICA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 141
  • TABLE 91 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 141
  • TABLE 92 SOUTH AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 142
  • TABLE 93 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 94 SAUDI ARABIA CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 95 SAUDI ARABIA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 96 SAUDI ARABIA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 144
  • TABLE 97 SAUDI ARABIA FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 98 SAUDI ARABIA RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 99 SAUDI ARABIA ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 100 SAUDI ARABIA INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 101 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 146
  • TABLE 102 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
  • TABLE 103 SAUDI ARABIA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 104 SAUDI ARABIA NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
  • TABLE 105 SAUDI ARABIA HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 147
  • TABLE 106 SAUDI ARABIA CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 148
  • TABLE 107 SAUDI ARABIA GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
  • TABLE 108 SAUDI ARABIA INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
  • TABLE 109 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 149
  • TABLE 110 SAUDI ARABIA RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 149
  • TABLE 111 SAUDI ARABIA CLINICAL IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 149
  • TABLE 112 SAUDI ARABIA COMPANION DIAGNOSTIC IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY USAGE, 2021-2030 (USD MILLION) 150
  • TABLE 113 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY END USER, 2021-2030 (USD MILLION) 150
  • TABLE 114 SAUDI ARABIA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 150
  • TABLE 115 EGYPT FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 116 EGYPT CONSUMABLES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 117 EGYPT FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PROBE TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 118 EGYPT FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 152
  • TABLE 119 EGYPT FISH PROBE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 120 EGYPT RNA IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 121 EGYPT ACCESSORY KITS & REAGENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 122 EGYPT INSTRUMENTS IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 123 EGYPT FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 154
  • TABLE 124 EGYPT FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
  • TABLE 125 EGYPT CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 126 EGYPT NON-HEMATOPOIETIC MALIGNANCIES (SOLID TUMORS) IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 155
  • TABLE 127 EGYPT HEMATOPOIETIC MALIGNANCIES IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 155
  • TABLE 128 EGYPT CANCER RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 156
  • TABLE 129 EGYPT GENETIC RESEARCH IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
  • TABLE 130 EGYPT INFECTIOUS DISEASE IN FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 32
  • FIGURE 2 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DATA TRIANGULATION 35
  • FIGURE 3 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DROC ANALYSIS 36
  • FIGURE 4 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 37
  • FIGURE 5 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY RESEARCH ANALYSIS 37
  • FIGURE 6 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: INTERVIEW DEMOGRAPHICS 38
  • FIGURE 7 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: MARKET APPLICATION COVERAGE GRID 40
  • FIGURE 8 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: DBMR MARKET POSITION GRID 42
  • FIGURE 9 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: VENDOR SHARE ANALYSIS 44
  • FIGURE 10 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SEGMENTATION 48
  • FIGURE 11 THE GROWING BURDEN OF GENETIC DISORDERS AS WELL AS CANCER AND HIGH FUNDING FOR RESEARCH ACTIVITIES IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET FROM 2023 TO 2030 49
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET IN 2023 AND 2030 49
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET 57
  • FIGURE 14 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2022 64
  • FIGURE 15 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 65
  • FIGURE 16 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 65
  • FIGURE 17 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 66
  • FIGURE 18 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2022 75
  • FIGURE 19 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 76
  • FIGURE 20 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, CAGR (2023-2030) 76
  • FIGURE 21 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY TECHNOLOGY, LIFELINE CURVE 77
  • FIGURE 22 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2022 83
  • FIGURE 23 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 84
  • FIGURE 24 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, CAGR (2023-2030) 84
  • FIGURE 25 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY APPLICATION, LIFELINE CURVE 85
  • FIGURE 26 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2022 95
  • FIGURE 27 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, 2023-2030 (USD MILLION) 96
  • FIGURE 28 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, CAGR (2023-2030) 96
  • FIGURE 29 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY USAGE, LIFELINE CURVE 97
  • FIGURE 30 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2022 103
  • FIGURE 31 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, 2023-2030 (USD MILLION) 104
  • FIGURE 32 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, CAGR (2023-2030) 104
  • FIGURE 33 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY END USER, LIFELINE CURVE 105
  • FIGURE 34 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2022 111
  • FIGURE 35 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 112
  • FIGURE 36 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 112
  • FIGURE 37 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 113
  • FIGURE 38 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: SNAPSHOT (2022) 119
  • FIGURE 39 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022) 120
  • FIGURE 40 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2023 & 2030) 120
  • FIGURE 41 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: BY COUNTRY (2022 & 2030) 121
  • FIGURE 42 MIDDLE EAST AND AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: PRODUCT TYPE (2023-2030) 122
  • FIGURE 43 MIDDLE EAST & AFRICA FLUORESCENT IN SITU HYBRIDIZATION (FISH) MARKET: COMPANY SHARE 2022 (%) 202
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!